| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 03/11/2008 | US7342015 Indole derivatives |
| 03/11/2008 | US7342005 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid; carbapenems derivatives containing a carboxy substituted phenyl group; broad spectrum antibacterial activity; good stability; beta-lactamases inhibitors; favourable duration of action; infections |
| 03/11/2008 | US7341700 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 03/11/2008 | US7341607 Yellow anionic disazo dyes |
| 03/11/2008 | CA2485298C Substituted pyrazolyl compounds for the treatment of inflammation |
| 03/11/2008 | CA2404464C Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders |
| 03/11/2008 | CA2340230C Pyridazinone derivatives having cell adhesion inhibiting activity |
| 03/11/2008 | CA2293382C Piperazine derivatives and their use as anti-inflammatory agents |
| 03/11/2008 | CA2192764C Integrin receptor antagonists |
| 03/06/2008 | WO2008028118A1 1h-indole-2-carboxylic acid derivatives useful as ppar modulators |
| 03/06/2008 | WO2008027385A2 Processes for the synthesis of 5-phenyl -1 trityl-1h-tetrazole |
| 03/06/2008 | WO2008026769A1 Novel aminopyridine derivative having aurora a-selective inhibitory activity |
| 03/06/2008 | WO2008026768A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 03/06/2008 | WO2008025886A1 Metal chelates and chelating agents containing triazolyl subunits |
| 03/06/2008 | WO2008025556A1 Sulphoximides as protein kinase inhibitors |
| 03/06/2008 | WO2008014361A3 Cyclic derivatives as modulators of chemokine receptor activity |
| 03/06/2008 | WO2008011176A9 Myosin light chain kinase inhibitor compounds, compositions and related methods of use |
| 03/06/2008 | WO2007146225A3 Heterocyclic aspartyl protease inhibitors |
| 03/06/2008 | WO2007122508A3 An improved process for the preparation of irbesartan |
| 03/06/2008 | WO2007117607A9 Quinazolines for pdk1 inhibition |
| 03/06/2008 | US20080058515 indazolylacrylamide derivatives are useful in the treatment of diseases associated with inappropriate SGK-1 activity |
| 03/06/2008 | US20080058356 2,6 Bisheteroaryl-4-Aminopyrimidines as Adenosine Receptor Antagonists |
| 03/06/2008 | US20080058342 potent kinase insert domain-containing receptor (KDR) inhibitors with improved selectivity and pharmacokinetics; VEGF (vascular endothelial growth factor) inhibitors; cancer and rheumatoid arthritis; e.g. 7-(2-[4-(acetylmethyl)piperazin-1-yl]ethoxy)-6-methoxy-4-[(2-methyl-1H-indol-5-yl)oxy]quinazoline |
| 03/06/2008 | US20080058334 Dermatological or oncological disorders; N-(4-fluorophenyl)-N'-[4-[1-(1H-imidazol-1-yl)-2-methylpropyl]phenyl]urea for example |
| 03/06/2008 | US20080058333 Carbamates such as (1-benzylcyclohexyl)methyl(1S)-5-[(4-morpholinylcarbonyl)amino]-1-(oxo([(1R)-1-phenylethyl]amino)acetyl)pentylcarbamate; osteoporosis |
| 03/06/2008 | US20080058332 Antiproliferative, antitumor agents; 4-(3-hydroxyphenyl)-6-morpholino-2-(3-piperidin-4-ylcarbonylaminophenyl)pyrimidine for example |
| 03/06/2008 | US20080058313 Tetrahydro-2h-indazole pyrazole cannabinoid modulators |
| 03/06/2008 | US20080058293 Quinoline Derivates and Their Use in Therapy |
| 03/06/2008 | US20080056991 Histamine H3 receptor inhibitors; (4-Azepan-1-ylmethyl-phenyl)-(4-isopropyl-piperazin-1-yl)-methanone dihydrochloride for example; allergies, nasal congestion, eating disorders, sleep disorders, neurodegenerative disorders |
| 03/06/2008 | US20080054223 Light Emitting Complex Salts |
| 03/06/2008 | CA2662274A1 Chemical compounds |
| 03/06/2008 | CA2661288A1 Carbamoylsulphoximides as protein kinase inhibitors |
| 03/06/2008 | CA2657469A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 03/05/2008 | EP1894927A1 The use of moxonidine salts for purification of moxonidine |
| 03/05/2008 | EP1894926A1 Polymorphs of moxonidine and processes for preparation therefor |
| 03/05/2008 | EP1893600A1 Trombin inhibiting 2,4-dioxo-3,4-dihydropyrimidine derivatives |
| 03/05/2008 | EP1893599A1 Compounds for the treatment of multi-drug resistant bacterial infections |
| 03/05/2008 | EP1893588A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 03/05/2008 | EP1893584A1 Dihydropyrimidone multimers and their use as human neutrophil elastase inhibitors |
| 03/05/2008 | EP1893581A1 Substituted arylpyrazoles for use against parasitites |
| 03/05/2008 | EP1893576A1 Treatment of protein folding disorders |
| 03/05/2008 | EP1893574A2 Peptide deformylase (pdf) inhibitors 4 |
| 03/05/2008 | EP1893573A1 Inhibitors of hcv replication |
| 03/05/2008 | EP1893212A2 Multicyclic compounds and methods of their use |
| 03/05/2008 | EP1893196A1 Diarylhydantoin compounds |
| 03/05/2008 | EP1633748B1 Quinoline derivatives as phosphodiesterase inhibitors |
| 03/05/2008 | EP1575926B1 New pyridazin-3(2h)-one derivatives |
| 03/05/2008 | EP1560811B9 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 03/05/2008 | CN101137652A Pyrimidine compounds having tie2 (tek) inhibitory activity |
| 03/05/2008 | CN101137649A Alkinyl-oxypyrimidine used in the form of pesticides |
| 03/05/2008 | CN101137645A Aryl piperazine derivatives for the treatment of neuropsychiatric disorders |
| 03/05/2008 | CN101137623A N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 03/05/2008 | CN101137382A Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
| 03/05/2008 | CN101134755A Quinazoline(di) ones for invertebrate pest control |
| 03/05/2008 | CN100372536C Tablets quickly disintegrated in oral cavity |
| 03/05/2008 | CN100372533C Therapeutic formulation for mainly of diarrhea large intesitine irritation syndrome |
| 03/05/2008 | CN100372532C Imidazolin-2-ylaminophenyl amides as IP antagonists. |
| 03/04/2008 | US7338974 Macrocyclic diaminopropanes as beta-secretase inhibitors |
| 03/04/2008 | US7338969 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial settings like ship hulls, food processing systems, oil recovery or paper making plants |
| 03/04/2008 | US7338959 N2-isopropyl-N5,1-dimethyl-N5-[2-({4-[(methylsulfonyl)methyl]phenyl}amino)pyrimidin-4-yl]-1H-benzimidazole-2,5-diamine; vascular endothelial growth factor (VEGF) receptor-2 and tyrosine kinase containing Ig and EGF homology domains (TIE) -2 inhibitor; antiproliferation and antihypoxic agent |
| 03/04/2008 | US7338956 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 03/04/2008 | US7338950 Amide compounds as ion channel ligands and uses thereof |
| 03/04/2008 | US7338947 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
| 02/28/2008 | WO2008024974A1 Pyrimidine and pyrazine derivatives |
| 02/28/2008 | WO2008024829A2 Radiohaloimatinibs and methods of their synthesis and use in pet imaging of cancers |
| 02/28/2008 | WO2008024784A1 Alkylsulfonamide-substituted triazoles as matrix metalloprotease inhibitors |
| 02/28/2008 | WO2008023239A1 Pyrimidone compounds as gsk-3 inhibitors |
| 02/28/2008 | WO2008023235A1 Pyrazole derivatives as anti-platelet and anti-thrombotic agents |
| 02/28/2008 | WO2008023159A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| 02/28/2008 | WO2008022979A1 New pyridone derivatives with mch antagonistic activity and medicaments comprising these compounds |
| 02/28/2008 | WO2008022945A1 Aryl sulfonamides with an analgesic action |
| 02/28/2008 | WO2008008551A3 2-substituted proline bis-amide orexin receptor antagonists |
| 02/28/2008 | WO2007139967A3 Triazole compounds that modulate hsp90 activity |
| 02/28/2008 | WO2007136596A3 Pesticidal compositions for treating arthropods and methods for the use thereof |
| 02/28/2008 | US20080051432 Piperidine-2, 6-dione derivatives and their use as tumor necrosis factor inhibitors |
| 02/28/2008 | US20080051414 Protein Kinase Inhibitors |
| 02/28/2008 | US20080051401 2,4,6-Trisubstituted Pyrimidines as Phosphotidylinositol (Pi) 3-Kinase Inhibitors and Their Use in the Treatment of Cancer |
| 02/28/2008 | US20080051389 mimetics of the Smac peptide, used for the treatment of cancer and autoimmune disorders |
| 02/28/2008 | US20080051384 Antiviral agents |
| 02/28/2008 | US20080050336 Hepatitis C Virus Inhibitors |
| 02/28/2008 | CA2663598A1 New compounds |
| 02/28/2008 | CA2661436A1 Isoquinoline, quinazoline and phthalazine derivatives |
| 02/28/2008 | CA2657183A1 New pyridone derivatives with mch antagonistic activity and medicaments comprising these compounds |
| 02/27/2008 | EP1892239A1 Inhibitors of cytosolic phospholipase A2 |
| 02/27/2008 | EP1891951A1 Viral polymerase inhibitors |
| 02/27/2008 | EP1891950A1 Viral polymerase inhibitors |
| 02/27/2008 | EP1891063A2 Bicyclic derivatives as modulators of ion channels |
| 02/27/2008 | EP1891058A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 02/27/2008 | EP1891057A1 Azab i cyclo [3 . 1 . 0] hexane derivatives as dopamin d3 receptor modulators |
| 02/27/2008 | EP1891056A1 Novel compounds |
| 02/27/2008 | EP1891055A2 Process for the preparation of losartan potassium |
| 02/27/2008 | EP1891054A1 Hydrates of alkaline-earth salts of irbesartan and the preparation thereof |
| 02/27/2008 | EP1891053A1 Method for obtaining benzimidazole derivatives and intermediates thereof |
| 02/27/2008 | EP1891052A1 Tubulin inhibitor and process for its preparation |
| 02/27/2008 | EP1891051A2 Solid forms of 1-( 5-(ih-i , 2 , 4 -triazol- 5 -yl)(1h-indazol-3-yl))-3-(2-piperidylethoxy)benzene |
| 02/27/2008 | EP1891050A1 New derivatives of pyrrolyltriazine together with methods for obtaining them and their use as protecting agents against uv radiation |
| 02/27/2008 | EP1891049A1 Method for producing 2-(2-amino-pyrimidin-4-yl)-1h-indole-5-carboxylic acid derivatives |
| 02/27/2008 | EP1891048A1 Pyrazole-substituted benzimidazole derivatives for use in the treatment of cancer and autoimmune disorders |
| 02/27/2008 | EP1891042A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their therapeutic use on the central nervous system |
| 02/27/2008 | EP1891019A2 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists |